Perry Davidson’s Syqe Medical has begun selling a medical cannabis inhaler that ensures that each patient is administered an exact dosage.
Eight Years And $83 Million Later, Syqe® Medical Releases First Cannabis Inhaler
Teva will market the company’s inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe® in 2016.